Journey Medical Corp (NAS:DERM)
$ 5.29 0.43 (8.85%) Market Cap: 109.65 Mil Enterprise Value: 105.54 Mil PE Ratio: 0 PB Ratio: 8.60 GF Score: 35/100

Q2 2023 Journey Medical Corp Earnings Call Transcript

Aug 08, 2023 / 08:30PM GMT
Release Date Price: $2.4 (+12.15%)
Operator

Ladies and gentlemen, thank you for standing by. Good afternoon and welcome to Journey Medical's second quarter 2023 financial results and corporate update conference call. (Operator Instructions) Participants of this call are advised that the audio of this conference call is being broadcast live over the Internet and is also being recorded for playback purposes. (Operator Instructions)

I would like now to turn the call over to Mr. Matt Blazei of CoreIR, the company's Investor Relations firm. Please go ahead, sir.

Matt Blazei
CoreIR - IR

Good afternoon, and thank you for participating in today's conference call. Joining me from Journey Medical Corporation's leadership team are Claude Maraoui, Co-Founder, President, and Chief Executive Officer; Joe Benesch, Interim Chief Financial Officer; Dr. Srinivas Sidgiddi, Vice President, Research and Development. And joining us for the Q&A session will be Dr. Neal Bhatia, Director of Clinical Dermatology at Therapeutics Clinical Research.

During this call, management will be making forward-looking

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot